Nishimura et al. [244] report a drop in both ERα and PgR expression from primary to metastatic tissue, with ERα and PgR levels dropping from 63.9 to 56.7 % respectively in primary tumour, to 57.7 and 43.3 % respectively in metastases. This evidence concerns the gene ESR1 and neoplasm.